Upon validation of these results in cervical cancer-derived cell lines, we found that the combined knockdown of both F-box protein 4 (FBXO4) and E6AP leads to a dramatic increase in the levels of endogenous HPV-18E6 oncoprotein. The gene discussed is FBXO4; the disease is cervical carcinoma.